INSUBCONTINENT EXCLUSIVE:
Sun Pharmaceutical rallied over 5 per cent early on Monday, spurred by its earnings show.
The company on Friday reported 6.93 per cent rise
in consolidated profit at Rs 1,375.62 crore for the quarter to March, which was above ET NOW poll of Rs 895 crore
The scrip was trading 5.06 per cent up at Rs 490.15 at around 9.28 am
The BSE Sensex was up 145 points, or 0.42 per cent, at 35,070.62
On the financial performance, Dilip Shanghvi, Managing Director, said: "Our Q4 performance is in line with our guidance
Over the last four quarters, we have been able to record a gradual improvement in performance despite a challenging US generic pricing
environment."
Global brokerage firm CLSA revised target price of Sun Pharma upwards to Rs 600 from Rs 445 earlier
